KRAS and pancreatic neoplasm: For instance, APC- or MYC-driven pancreatic tumors were sensitive to depletion of serine and glycine, leading to reduced growth; in contrast, KRAS-driven tumors were not affected by serine and glycine removal (Maddocks et al, 2017).